Arcutis Biotherapeutics, Inc. - stock earnings
ARQT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -66.3 million USD | 13.5 million USD |
| 2023Q3 | -44.8 million USD | 38.1 million USD |
| 2023Q2 | -71.0 million USD | 5.2 million USD |
| 2023Q1 | -79.7 million USD | 2.8 million USD |
| 2022Q4 | -75.6 million USD | 3.0 million USD |
| 2022Q3 | -110.7 million USD | 725000 USD |
| 2022Q2 | -69.0 million USD | ? USD |
| 2022Q1 | -66.0 million USD | ? USD |
| 2021Q4 | -71.3 million USD | ? USD |
| 2021Q3 | -57.0 million USD | ? USD |
| 2021Q2 | -42.0 million USD | ? USD |
| 2021Q1 | -36.0 million USD | ? USD |
| 2020Q4 | -34.0 million USD | ? USD |
| 2020Q3 | -38.2 million USD | ? USD |
| 2020Q2 | -35.4 million USD | ? USD |
| 2020Q1 | -28.0 million USD | ? USD |
| 2019Q4 | -12.6 million USD | ? USD |
| 2019Q3 | -14.5 million USD | ? USD |
| 2019Q2 | -8.3 million USD | ? USD |
| 2019Q1 | -6.7 million USD | ? USD |
| 2018Q4 | -5.6 million USD | ? USD |
| 2018Q3 | -7.7 million USD | ? USD |
| 2018Q2 | -6.0 million USD | ? USD |
ARQT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -262.1 million USD | 59.6 million USD |
| 2022 | -321.3 million USD | 3.7 million USD |
| 2021 | -205.9 million USD | ? USD |
| 2020 | -135.7 million USD | ? USD |
| 2019 | -42.0 million USD | ? USD |
| 2018 | -19.3 million USD | ? USD |
| 2017 | -5.0 million USD | ? USD |
ARQT
Price: $8.47
52 week price:
Earnings Per Share: -3.78 USD
P/E Ratio: -1.40
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 827862
Market Capitalization: 1.3 billion